Podcasts about severe covid

In his weekly clinical update, Dr. Griffin with Vincent Racaniello are dismayed about the recent attack on public health the firing of the director of the CDC as well as resignation of 3 others members of the agency's leadership, the continued Legionnaire's outbreak in Harlem, suspension of Ixchiq the Chikungunya virus attenuated infectious vaccine, the first US case of New World screwworm before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, association Guillian-Barré syndrome with RSV vaccination, guidelines for using RSV vaccines, whether or not the NB.1.8.1 should be included in the fall 2025 vaccines, the American College Obstetricians and Gynecologists recommendations for the COVID, RSV and influenza vaccines, FDA approval letters for Pfizer, moderna and Novagax COVID vaccines including label changes for use in those between 5 through 64 years, where to find PEMGARDA, long COVID treatment center, where to go for answers to your long COVID questions, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode White House Says New C.D.C. Director Is Fired, but She Refuses to Leave (NY Times) CDC director refuses to leave after White House order (BBC) Legionnaires' Disease: In Harlem(NYC Health) New York City Health Department Provides Update on Community Cluster of Legionnaires' Disease in Central Harlem(NYC Health: Promoting and protecting the City's health) FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live) (FDA) Vimkunya (Bavarian Nordiac) U.S. and Panama for the control of the Screwworm pest (COPEG) Rare human case of flesh-eating parasite New World screwworm identified in US(CNN) USDA Announces Sweeping Plans to Protect the United States from New World Screwworm (USDA) HHS details New World screwworm response after human case(CIDRAP) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Measles vaccine recommendations from NYP (jpg) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score (JID) FDA-CDC-DOD: 2025-2046 influenza vaccine composition (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) ENFLONSIA: novel drug approvals 2025 (FDA) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Evaluation of Guillain-Barré Syndrome (GBS) following Respiratory Syncytial Virus (RSV) Vaccination Among Adults 65 Years and Older (FDA) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Evidence to Recommendations Framework (EtR): RSV Vaccination in Adults Aged 50–59 years (CDC: National Center for Immunization and Respiratory Diseases) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Veering from CDC, ACOG recommends maternal vaccination against COVID-19 (CIDRAP) ACOG Releases Updated Maternal Immunization Guidance for COVID-19, Influenza, and RSV (American College of Obstericians and Gynecologists) COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care (American College of Obstericians and Gynecologists) Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19 (Pfizer)  COMIRNATY approval letter (FDA) Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 (FEEDS) SPIKEVAX approval letter (FDA) Novavax's Nuvaxovid 2025-2026 Formula COVID-19 Vaccine Approved in the U.S (Novavax) NUVAXOVID approval letter (FDA) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Paxlovid (Pfizer) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Steroids,dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1248 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Listen in as Cristina Mussini, MD; Martin Witzenrath, MD, FERS; and Michele Bartoletti, MD, PhD, discuss treatment strategies for people who are immunocompromised with COVID-19 in the hospital setting, including: Antiviral therapy with remdesivirDexamethasone for patients with hematologic malignanciesConsiderations regarding other immunomodulators such as JAK inhibitors or IL-6 inhibitorsA detailed patient case to illustrate key takeaways Presenters:Michele Bartoletti, MD, PhD​Associate Professor of Infectious DiseasesDepartment of Biomedical SciencesHumanitas UniversityPieve Emanuele (MI), ItalyHead of Infectious Diseases UnitIRCCS Humanitas Research HospitalRozzano (MI), ItalyCristina Mussini, MD​Full Professor of Infectious DiseasesChief of the Department of Infectious DiseasesUniversity of Modena and Reggio EmiliaModena, ItalyMartin Witzenrath, MD, FERS Medical DirectorCharite Centrum 12Internal Medicine & DermatologyProfessor and Chair for Respiratory Medicine and Critical CareDepartment of Infectious Disease, Respiratory Medicine and Critical CareCharite Campus Mitte/Campus Virchow Klinikum/Campus Benamin FranklinCharite – University of BerlinBerlin, GermanyLink to full program:https://bit.ly/4fs7HcbDownloadable slides:https://bit.ly/3XP1fpJGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss: Workup of COVID-19 in the emergency departmentMethods of COVID-19 risk stratification Treatment recommendations for people with severe COVID-19, including how to effectively use antiviral therapy, dexamethasone, and other immunomodulators[CC1] in this population A detailed patient case to illustrate key takeawaysPresenters:Stephen Cantrill, MD, FACEP​Associate Director and Medical Director (Retired) ​ Department of Emergency Medicine​ Denver Health Medical Center​ Associate Professor ​ Department of Emergency Medicine​ University of Colorado Health Sciences Center​ Denver, Colorado Rajesh T. Gandhi, MD​Massachusetts General Hospital​ Professor of Medicine​ Harvard Medical School​ Boston, Massachusetts Payal K. Patel, MD, MPH, FIDSA​Systemwide Director of Antimicrobial Stewardship​ Associate Professor, Division of Infectious Diseases​ Intermountain Health​ Salt Lake City, Utah Link to full program: https://bit.ly/4gu2gcUGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss treatment strategies for people who have severe COVID-19, including: Antiviral therapy with remdesivir Dexamethasone and other systemic corticosteroids Immunomodulators, such as JAK inhibitors or IL-6 inhibitors Overviews of clinical trial data demonstrating how and when to use these therapiesPresenters:Stephen Cantrill, MD, FACEP​Associate Director and Medical Director (Retired) ​ Department of Emergency Medicine​ Denver Health Medical Center​ Associate Professor ​ Department of Emergency Medicine​ University of Colorado Health Sciences Center​ Denver, Colorado Rajesh T. Gandhi, MD​Massachusetts General Hospital​ Professor of Medicine​ Harvard Medical School​ Boston, Massachusetts Payal K. Patel, MD, MPH, FIDSA​Systemwide Director of Antimicrobial Stewardship​ Associate Professor, Division of Infectious Diseases​ Intermountain Health​ Salt Lake City, Utah Link to full program: https://bit.ly/4gu2gcUGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.    

In this episode, Cristina Mussini, MD, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss:Current SARS-CoV-2 trends in the EURisk factors for severe COVID-19 outcomes, including the spectrum of risk based on immune system statusFactors that may affect vaccine efficacy in chronic lymphocytic leukemia and other lymphoid malignanciesConsiderations for determining people at high risk for COVID-19 progression Presenters:Cristina Mussini, MDFull Professor of Infectious DiseasesDivision of Infectious DiseasesUniversity of Modena and Reggio EmiliaModena, ItalyMartin Witzenrath, MD, FERSMedical DirectorCharite Centrum 12Internal Medicine & DermatologyProfessor and Chair for Respiratory Medicine and Critical CareDepartment of Infectious Disease, Respiratory Medicine and Critical CareCharite Campus Mitte/Campus Virchow Klinikum/Campus Benjamin FranklinCharite – University of BerlinBerlin, GermanyMichele Bartoletti, MD, PhDAssociate Professor of Infectious DiseasesDepartment of Biomedical SciencesHumanitas UniversityPieve Emanuele (MI), ItalyHead of Infectious Diseases UnitIRCCS Humanitas Research HospitalRozzano (MI), ItalyLink to full program: https://bit.ly/4gu2gcUDownloadable slides: https://bit.ly/42IlpELGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss current trends in and risk factors for progression to severe COVID-19, including for those for whom COVID-19 is not their primary concern when presenting to the emergency department (ED). Key topics of discussion include: How to complete a comprehensive patient workup in the EDConsiderations regarding pulse oximetryRisk stratification—what places patients at higher risk of severe disease?A detailed patient case to illustrate key takeawaysPresenters:Stephen Cantrill, MD, FACEP​Associate Director and Medical Director (Retired) ​Department of Emergency Medicine​Denver Health Medical Center​Associate Professor ​Department of Emergency Medicine​University of Colorado Health Sciences Center​Denver, ColoradoRajesh T. Gandhi, MD​Massachusetts General Hospital​Professor of Medicine​Harvard Medical School​Boston, MassachusettsPayal K. Patel, MD, MPH, FIDSA​Systemwide Director of Antimicrobial Stewardship​Associate Professor, Division of Infectious Diseases​Intermountain Health​Salt Lake City, UtahLink to full program:https://bit.ly/4fs7HcbGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about the impact of air quality on how you feel on a particular day, the unusual surge of “walking pneumonia,” especially among kids, the amount of COVID in the community being down, why now is a great time to get […]

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about the impact of air quality on how you feel on a particular day, the unusual surge of “walking pneumonia,” especially among kids, the amount of COVID in the community being down, why now is a great time to get […]

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about the impact of air quality on how you feel on a particular day, the unusual surge of “walking pneumonia,” especially among kids, the amount of COVID in the community being down, why now is a great time to get […]

Vice presidential nominee Tim Walz takes center stage tonight at the Democratic National Convention in Chicago. US government officials are hammering out the final details of a ceasefire proposal between Israel and Hamas. Divers recovered four bodies today in the search for those missing from a superyacht that sank off the coast of Sicily earlier this week. A deadly shooting inside a school in Bosnia is under investigation. And, new research looks at the impact a severe case of Covid-19 could have on your mental health. Learn more about your ad choices. Visit podcastchoices.com/adchoices

The Overlooked Power of Nutrition: Dr. John Lewis' Journey to Health and Wellness In this episode of the Medical Entrepreneur Podcast, host Dr. Sewell talks with Dr. John Lewis, a former academic turned nutrition entrepreneur. Dr. Lewis shares his journey from being a physiologist at the University of Miami to developing a successful dietary supplement business. They discuss the often-neglected importance of nutrition in health and wellness, highlighting Dr. Lewis' groundbreaking research on polysaccharides from aloe vera and rice bran, and their significant impact on brain health, Alzheimer's, multiple sclerosis, and overall immune function. Learn how Dr. Lewis combines scientific credibility with ethical marketing to offer a holistic approach to health. 00:00 The Overlooked Power of Nutrition 00:33 Introducing Dr. John Lewis 01:04 The Entrepreneurial Side of Academia 02:07 Transitioning from Academia to Business 03:05 The Science Behind Polysaccharides 06:10 The Importance of Proper Nutrition06:34 Challenges in Modern Nutrition 10:58 Understanding Polysaccharides 18:03 Breakthrough Research on Alzheimer's 19:31 Clinical Trials and Findings 29:00 Challenges in Academic Research 31:29 Exciting Results in MS Research 35:16 Implementing Nutritional Supplements in Practice 36:25 Addressing Cognitive Decline Post-Vaccination 37:05 Case Study: Recovery from Severe COVID-19 Complications 38:15 The Power of Polysaccharides in Healing 40:10 Daily Brain Care: A Comprehensive Solution 43:54 The Importance of Prevention in Health 46:18 Exploring the Science Behind Polysaccharides 49:44 Introducing Daily Brain Care Ingredients 55:33 How Practitioners Can Integrate Daily Brain Care 58:22 The Ethical Approach to Supplementation 01:03:54 Conclusion and Final Thoughts

News

News

Following up on our Long COVID episode with Tara Haelle, Matthew will be expanding the Listener Stories portfolio with stories from listeners about navigating Long COVID. Why? Because there's nothing like a mysterious disease, denied by some, stigmatized by others, and politicized by multiple interests, that will bring a person closer to the appeal of alt-med conspirituality. Matthew Stillman is our guest today. Author, documentary filmmaker, and lifelong New Yorker, Stillman grew up in an eccentric family of spiritualism and alternative medicine, but which also fostered a healthy respect for evidence-based medicine. So what happens when experts at Mt. Sinai Center for Post-COVID care reach the end of their capacity to help him with not one but two strains of Long COVID? Red light therapy! Chinese herbs! And a bracing contemplation of what it means to explore the tension between hope and knowledge. Show Notes Matthew Stillman The major genetic risk factor for severe COVID-19 is inherited from Neanderthals | Nature How Genes from Neanderthals Predispose People to Severe COVID-19 | The Scientist Magazine Learn more about your ad choices. Visit megaphone.fm/adchoices

Host Marilyn N. Bulloch, PharmD, BCPS, FCCM, is joined by Joy Peterson, PharmD, BCPS, BCIDP, Neha Paranjape, MD, MPH, to discuss the article, "Outcomes and Adverse Effects of Baricitinib Versus Tocilizumab in the Management of Severe COVID-19," (Crit Care Med. March 2023 51(3):337-346) which delves into the comparative outcomes, mortality rates, and adverse effects of baricitinib and tocilizumab in severe COVID-19 cases. Dr. Peterson is a Clinical Pharmacy Specialist in infectious disease, and Dr. Paranjape is an Infectious Disease Specialist at Wellstar Health System in Marietta, Georgia.

AP correspondent Haya Panjwani reports on the usage of the COVID-19 drug called Paxlovid

Did you know that in the United States, around 3% of the adult population are moderately or severely immunocompromised? Credit available for this activity expires: 12/29/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999379?ecd=bdc_podcast_libsyn_mscpedu

A round-up of the main headlines in Sweden on August 23rd, 2023. You can hear more reports on our homepage radiosweden.se, or in the app Sveriges Radio Play. Presenter: Dave RussellProducer: Kris Boswell

A ninety-three year old woman who does not practice Falun Dafa but believes in it, is protected from the Covid virus, a heart attack and various other incidents. This and other stories from the Minghui website. Original Articles:1. [Celebrating World Falun Dafa Day] How My Ninety-Year-Old Mother Recovered from Severe COVID Infection2. Experience Sharing Conference […]

DrBeen#61 Clotting in Severe COVID Patients May Be An Immune Pathology For the first time, this new study shows the possibility of autoreactive immune pathology leading to clotting in severe COVID patients. In Dr. Been's opinion, this mechanism may be behind the clotting found in patients with long COVID and vaccine injury as well. DrBeen: Medical Education Online https://www.drbeen.com/ FLCCC | Front Line COVID-19 Critical Care Alliance https://covid19criticalcare.com/ URL list from Friday, July 7, 2023 Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019 - PMC https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307883/ The ADAMTS13‐von Willebrand factor axis in COVID‐19 patients - PMC https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753796/ Physiology, Von Willebrand Factor - StatPearls - NCBI Bookshelf https://www.ncbi.nlm.nih.gov/books/NBK559062/ von Willebrand factor - Wikipedia https://en.wikipedia.org/wiki/Von_Willebrand_factor ADAMTS13 - Wikipedia https://en.wikipedia.org/wiki/ADAMTS13 Role of von Willebrand factor in the haemostasis - PMC https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159913/ The factor VIII/von Willebrand factor complex: basic and clinical issues - PubMed https://pubmed.ncbi.nlm.nih.gov/12826528/ Platelet α–granules: Basic biology and clinical correlates - PMC https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720568/ JCM | Free Full-Text | Age-Associated Increase in Thrombogenicity and Its Correlation with von Willebrand Factor https://www.mdpi.com/2077-0383/10/18/4190 Dynamics and Plasticity of Weibel-Palade Bodies in Endothelial Cells | Arteriosclerosis, Thrombosis, and Vascular Biology https://www.ahajournals.org/doi/10.1161/01.atv.0000209501.56852.6c Disclaimer: This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.

Roger Seheult, MD of MedCram examines vilobelimab in the treatment of severe COVID with possible applications in the treatment of other diseases. See all Dr. Seheult's videos at: https://www.medcram.com (This video was recorded on May 7th, 2023) Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT: Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-contact Video Produced by Kyle Allred FOLLOW US ON SOCIAL MEDIA: https://www.facebook.com/MedCram https://twitter.com/MedCramVideos https://www.instagram.com/medcram DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor. #COVID19 #Omicron #Coronavirus

Drs Michael S. Saag and Monica Gandhi discuss COVID-19 and the impact this pandemic has had on patients diagnosed with HIV, including vaccines, boosters, and patients who are older or have chronic comorbid conditions. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986505). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Coronavirus Disease 2019 (COVID-19) https://emedicine.medscape.com/article/2500114-overview HIV Infection and AIDS https://emedicine.medscape.com/article/211316-overview HIV https://www.who.int/news-room/fact-sheets/detail/hiv-aids Molnupiravir, an Oral Antiviral Treatment for COVID-19 https://pubmed.ncbi.nlm.nih.gov/34159342/ Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients https://pubmed.ncbi.nlm.nih.gov/34914868/ Molnupiravir for the Treatment of COVID-19 in Immunocompromised Participants: Efficacy, Safety, and Virology Results From the Phase 3 Randomized, Placebo-Controlled MOVe-OUT Trial https://pubmed.ncbi.nlm.nih.gov/36648627/ Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Adults With COVID-19 at Increased Risk of Adverse Outcomes (PANORAMIC): An Open-Label, Platform-Adaptive Randomised Controlled Trial https://pubmed.ncbi.nlm.nih.gov/36566761/ Paxlovid https://pubmed.ncbi.nlm.nih.gov/35138785/ Protease Inhibitors as Promising Weapons Against COVID-19: Focus on Repurposing of Drugs Used to Treat HIV and HCV Infections https://pubmed.ncbi.nlm.nih.gov/34727849/ A Trial of Lopinavir-Ritonavir in Adults Hospitalized With Severe Covid-19 https://pubmed.ncbi.nlm.nih.gov/32187464/ Tenofovir Disoproxil Fumarate and Coronavirus Disease 2019 Outcomes in Men With HIV https://pubmed.ncbi.nlm.nih.gov/35848570/ Development of COVID-19 Vaccines–An Unanticipated Moon Shot Achieved at Warp Speed https://pubmed.ncbi.nlm.nih.gov/36689231/ Emerging Viral Diseases From a Vaccinology Perspective: Preparing for the Next Pandemic https://pubmed.ncbi.nlm.nih.gov/29199281/ A Bivalent Omicron-Containing Booster Vaccine Against Covid-19 https://pubmed.ncbi.nlm.nih.gov/36112399/ New Boosters Are Here! Who Should Receive Them and When? https://pubmed.ncbi.nlm.nih.gov/36354037/ Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients https://pubmed.ncbi.nlm.nih.gov/35653428/ Nirmatrelvir Use and Severe Covid-19 Outcomes During the Omicron Surge https://pubmed.ncbi.nlm.nih.gov/36001529/

Dr. Sabine Hazan is a gastroenterologist and CEO of Progenabiome. She is an expert on gut bacteria. When she started studying the microbiomes of COVID-19 patients, she quickly noticed a pattern.“The people that had severe COVID lacked a certain bacteria called bifidobacteria,” she says.In this episode, she breaks down how a healthy gut impacts people's outcomes from COVID-19, and what steps people can take to improve their gut health and overall immunity.With the knowledge Hazan gained from studying the microbiomes of COVID-19 patients, she developed and patented treatment protocols combining vitamins and drugs that increase bifidobacteria including vitamin C, vitamin D, hydroxychloroquine, and ivermectin.We also discuss how the COVID-19 vaccines impact the microbiome, including the microbiomes of babies breastfeeding from recently vaccinated mothers.

Dr. Jill Sylvester reviews the article, “Physical Inactivity is Associated with a Higher Risk for Severe COVID-19 Outcomes: A Study in 48,440 Adult Patients,” which was originally published in the British Journal of Sports Medicine in April 2021. Dr. Jeremy Schroeder serves as moderator. Dr. Sylvester is a member of the AMSSM Top Articles Subcommittee, and this episode is part of an ongoing mini journal club series highlighting each of the Top Articles in Sports Medicine from 2021, as selected for the 2022 AMSSM Annual Meeting in Austin, TX.   Physical Inactivity is Associated with a Higher Risk for Severe COVID-19 Outcomes: A Study in 48,440 Adult Patients DOI: 10.1136/bjsports-2021-104080

A breakneck pace and a lack of transparency are marking COVID-19's spread to hundreds of millions of people in the world's most populous nation. But how deadly will China's virus surge get? Beijing said the virus wave has already passed its peak, and that the daily death rate has dropped over 70 percent. But a new model predicted just the opposite. And locals say caskets are selling out, as losses mount in rural China. Will the country see a COVID-19 rebound? Or is the current wave already over? And what's the real situation surrounding China's outbreak? ⭕️ Watch in-depth videos based on Truth & Tradition at Epoch TV

More Severe COVID-19 Wave to Hit China: StudyWhite House on China COVID-19 TransparencyIs Pfizer's Paxlovid Drug Too Expensive for China?Fentanyl Precursor from China Seized in U.S.Nigeria Opens Deep Seaport Owned by ChinaChina Nationals Arrested for Smuggling Lithium Stones2 Dead, 7 Missing in China Dam IncidentRep. Tiffany's New Bill to Normalize Taiwan RelationsPut the China Issue at the Forefront of the Vote: Corr

More Severe COVID-19 Wave to Hit China: Study

China's National Health Commission says the number of COVID patients has declined at fever clinics, emergency centers, and ICUs across the country.

On a healthy plant-based diet, I've reversed Type 2 Diabetes and sky-high cholesterol. By Lauri Perrella at ForksOverKnives.com   Original post:  https://www.forksoverknives.com/success-stories/healthy-plant-based-diet-ive-reversed-type-2-diabetes-and-high-cholesterol/    Related Episodes: 387: Plant Based Diet Linked to Lower Risk of Severe Covid   Forks Over Knives Documentary: https://www.forksoverknives.com/the-film/    Forks Over Knives was founded following the release of the world-famous documentary Forks Over Knives in 2011, showing people how to regain control of their health and their lives with a plant-based diet. Since then Forks Over Knives released bestselling books, launched a mobile recipe app and maintains a website filled with the latest research, success stories, recipes, and tools to help people at every phase of their plant-based journeys. They also have a cooking course, a meal planner, a line of food products, and a magazine. Please visit www.ForksOverKnives.com for a wealth of resources.    How to support the podcast: Share with others. Recommend the podcast on your social media. Follow/subscribe to the show wherever you listen. Buy some vegan/plant based merch: https://www.plantbasedbriefing.com/shop    Follow Plant Based Briefing on social media: Twitter: @PlantBasedBrief YouTube: YouTube.com/PlantBasedBriefing  Facebook: Facebook.com/PlantBasedBriefing  LinkedIn: Plant Based Briefing Podcast Instagram: @PlantBasedBriefing #vegan #plantbased #plantbasedpodcast #veganpodcast #plantbasedbriefing #forksoverknives #wfpb #wholefoodplantbased #plantbaseddiet #type2diabetes #cholesterol #highbloodpressure #hypertension #standardamericandiet #gamechangers #whatthehealth #cowspiracy #esselstyn #covid #weightloss #heartdisease    

AP correspondent Ed Donahue on WHO China

Brian Spegele, China correspondent for the Wall Street Journal, discusses protests which have broken out across several Chinese cities over China's stringent Covid-19 restrictions as demonstrators and police clashed.

What are FIASMA psychotropics? What do they have to do with COVID-19? In this episode, we discuss a recent study that compared rates of severe illness among patients who, when admitted for COVID-19, were or were not taking a FIASMA—a functional inhibitor of acid sphingomyelinase activity. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 40 Association Between FIASMA Psychotropic Medications and Reduced Risk of Intubation or Death in Individuals With Psychiatric Disorders Hospitalized for Severe COVID-19: An Observational Multicenter Study

In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including:COVID-19 vaccines, including omicron BA.1 bivalent boosterRisk factors for breakthrough COVID-19 infectionsCOVID-19 diagnostics, including digital droplet PCRCOVID-19 therapeutics, including:Nirmatrelvir plus ritonavirTixagevimab plus cilgavimabBaricitinibTocilizumabInhaled interferon β-1aCOVID-19 therapeutics and outcomes in patients with immunocompromiseLong COVIDPresenters:Princy N. Kumar, MD, FIDSA, MACPProfessor of Medicine and MicrobiologyChief, Division of Infectious Diseases and Travel MedicineSenior Associate Dean of StudentsGeorgetown University School of MedicineWashington, DCPaul E. Sax, MDClinical DirectorHIV Program and Division of Infectious DiseasesBrigham and Women's HospitalProfessor of MedicineHarvard Medical SchoolBoston, MassachusettsFollow along with the downloadable slideset at:http://bit.ly/3gkJI67Link to full program:http://bit.ly/3TSVthM

Democrats Hold Senate as House Balance of Power Remains TBD, Four Corners to Meet on Inclusion of FDA Reforms in Year-End Package, Lawmakers Considering Extension of Telehealth Flexibilities, Finance Committee Releases Mental Health Care Integration Discussion Draft, McCarthy Announces GOP Transition Teams for 118th Congress, CMMI Releases New Strategy on Value-Based Specialty Care, HHS Argues No Surprises Act Rule Should Stand, FDA Grants EUA to Rheumatoid Arthritis Drug for Treatment of Severe COVID, Call to Order

Why do many severe COVID-19 survivors experience exercise intolerance as a lingering consequence of their viral infection? In this episode, Guest Editor Dr. Tiago Peçanha (Manchester Metropolitan University) interviewed lead author Dr. Hamilton Roschel (University of Sao Paulo) and expert Dr. John Durocher (Purdue University Northwest) about the latest study by Longobardi et al., which investigated the impact of previous severe COVID-19 infection on cardiorespiratory responses to a maximal exercise test. The authors enrolled survivors of severe COVID-19 who had previously been admitted to an intensive care unit during the acute phase of their illness in this cross-sectional study within a randomized controlled trial. The authors found that VO2 kinetics were significantly impaired at the onset and recovery phases of the exercise protocol in the COVID survivors. What do these experts think about the central and peripheral factors underlying the exertional intolerance and chronotropic incompetence in COVID survivors? Listen now.   Igor Longobardi, Danilo Marcelo Leite do Prado, Karla Fabiana Goessler, Matheus Molina Meletti, Gersiel Nascimento de Oliveira Júnior, Danieli Castro Oliveira de Andrade, Bruno Gualano, Hamilton Roschel Oxygen uptake kinetics and chronotropic responses to exercise are impaired in survivors of severe COVID-19 Am J Physiol Heart Circ Physiol, published September 2, 2022. DOI: 10.1152/ajpheart.00291.2022

Plant based diets are linked to lower risk of severe Covid. By Dana Hudepohl at ForksOverKnives.com. Original post: https://www.forksoverknives.com/wellness/plant-based-diets-linked-to-lower-risk-of-severe-covid-19-in-new-study/ Related Episodes:  4: The Path to Recovery Through Nutrition: Our Most Important Defense Against COVID-19 373: P1 Healing Autoimmune Disease With Supermarket Foods 374: P2 Healing Autoimmune Disease With Supermarket Foods   Forks Over Knives Documentary: https://www.forksoverknives.com/the-film/    Forks Over Knives was founded following the release of the world-famous documentary Forks Over Knives in 2011, showing people how to regain control of their health and their lives with a plant-based diet. Since then Forks Over Knives released bestselling books, launched a mobile recipe app and maintains a website filled with the latest research, success stories, recipes, and tools to help people at every phase of their plant-based journeys. They also have a cooking course, a meal planner, a line of food products, and a magazine. Please visit www.ForksOverKnives.com for a wealth of resources.    How to support the podcast: Share with others. Recommend the podcast on your social media. Follow/subscribe to the show wherever you listen. Buy some vegan/plant based merch: https://www.plantbasedbriefing.com/shop    Follow Plant Based Briefing on social media: Twitter: @PlantBasedBrief YouTube: YouTube.com/PlantBasedBriefing  Facebook: Facebook.com/PlantBasedBriefing  LinkedIn: Plant Based Briefing Podcast Instagram: @PlantBasedBriefing #vegan #plantbased #plantbasedpodcast #veganpodcast #plantbasedbriefing #forksoverknives #wfpb #wholefoodplantbased #plantbaseddiet #highprotein #keto #covid #longcovid #nutrientdense #hypernourish #covid19  

In this episode, we review Paxlovid (nirmatrelvir/ritonavir) from the perspective of its pharmacology, efficacy, safety, pharmacists' authority to prescribe, drug interactions, and rebound symptoms after Paxlovid therapy. Key Concepts Paxlovid is the preferred outpatient therapy for COVID-19 in patients at high risk for progressing to severe COVID-19. It likely has similar efficacy to IV monoclonal antibodies and IV outpatient remdesivir but differences in vaccination rates and patient populations makes a direct comparison difficult. The 5-day course of Paxlovid is generally well tolerated. “Paxlovid mouth” (dysgeusia) is relatively common and is characterized by a terrible metallic or garbage-like taste in the mouth during therapy. As of July 2022, licensed pharmacists have the authority to assess patients for Paxlovid and prescribe the therapy; however, Medicare/Medicaid reimbursement has not clearly established how reimbursement of clinical services can occur. “Rebound” COVID-19 symptoms may or may not be due to Paxlovid (versus the natural course of the disease). If rebound symptoms occur, they are almost always mild or asymptomatic in nature and do not require additional treatment. References DailyMed - PAXLOVID- nirmatrelvir and ritonavir kit (nih.gov). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7bdddfba-bd31-44cb-ba9e-23a4e17a4691 Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals. CDC. June 15, 2022. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html EPIC-HR Study: Hammond J, Leister-Tebbe H, Gardner A, et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19. N Engl J Med. 2022;386(15):1397-1408. doi:10.1056/NEJMoa2118542. https://www.nejm.org/doi/full/10.1056/NEJMoa2118542 COVID-19 Rebound After Paxlovid Treatment. CDC Health Alert Network. May 24, 2022. https://emergency.cdc.gov/han/2022/han00467.asp FDA Authorizes Pharmacists to Prescribe Paxlovid with Certain Limitations. Administration for Strategic Preparedness & Response (ASPR). July 6, 2022. https://aspr.hhs.gov/COVID-19/Therapeutics/updates/Pages/important-update-06July2022.aspx PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers. https://www.fda.gov/media/158165/download

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the September 20, 2022, issue.

Severe COVID-19 ‘Rare' In Unvaccinated People, Survey Reveals https://www.medicaldaily.com/severe-covid-19-rare-unvaccinated-people-survey-reveals-465612 Anthony Fauci, the disease expert who helped lead America's pandemic response, tests positive for COVID-19 https://www.msn.com/en-us/health/medical/anthony-fauci-the-disease-expert-who-helped-lead-americas-pandemic-response-tests-positive-for-covid-19/ar-AAYvnAs Normalizing Mass Hysteria https://www.nytimes.com/2022/06/15/opinion/mass-hysteria-trump.html Fight back against what's happening in the world. Stand up, protect yourself, and find out how to secure your new life abroad Register now free! https://ExpatMoneySummit.com Join the private discord & chat during the show! joingml.com Need someone to talk to? Betterhelp.com/gml Interested in learning how to Day Trade? Mastermytrades.com Like our intro song? https://www.3pillmorning.com Advertise on our podcast! Learn more about your ad choices. Visit megaphone.fm/adchoices

What are the neuropsychiatric effects of severe COVID-19? Find out this and more in today's PV Roundup podcast.

What are the neuropsychiatric effects of severe COVID-19? Find out this and more in today's PV Roundup podcast.

What are the neuropsychiatric effects of severe COVID-19? Find out this and more in today's PV Roundup podcast.

This new model I developed explains how the depletion of arginine and tryptophan and the sequestration of cysteine leads to T cell suppression in severe COVID and may reflect the rapid onset of a somewhat cancer-reminiscent state where vitamins A and D and other myeloid differentiation factors run out. The written version with references and links to research is available here: https://chrismasterjohnphd.substack.com/p/a-new-paradigm-for-severe-covid If you find this valuable, please like, share, and comment on the Substack article to help boost it within the Substack algorithm and get more people to read it. Vitamins A and D should be properly balanced with each other, and with vitamins E and K. My COVID-specific recommendations for this balance are in the COVID Guide, and recommendations for balancing them in various different contexts are included in the Vitamins and Minerals 101 Cliff Notes, both of which are freely available to paid Substack subscribers. These also contain general (Cliff Notes) or COVID-specific (COVID Guide) information for managing all the other nutrients mentioned. I will be updating the COVID guide next time to include tryptophan and N-acetylcysteine whenever arginine is used, but other than that this new paradigm does not alter the protocol. It does, however, move much more emphasis to A and D, and bring A onto much more equal footing with D. Disclaimer I am not a medical doctor and this is not medical advice. My goal is to empower you with information. Please make all health decisions yourself, consulting sources you trust, including a caring health care professional. Paid Subscriptions, Coming Guides, the Book My current plan is to wrap up a vaccine side effect protocol and my general work on the vaccines into a COVID Vaccine Guide that will be free to those who have pre-ordered my book, Masterpass members, and paid Substack subscribers. I will then do one final update to the COVID guide, also free to everyone I just mentioned. Paid Substack subscribers and Masterpass members will also have access to all paid-only Substack posts, which are the posts that feed into the creation of the vaccine side effect protocol. Most of these will be available for 48 hours to everyone. You can become a paid Substack subscriber here, which earns you 50% off the fee on Masterpass membership if you choose to join. The book can be pre-ordered here. As soon as these two guides are finished I will return full-time to finishing the book and will send everyone who pre-ordered an ETA as soon as I am ready. Take a Look at the Store At no extra cost to you, please consider buying products from one of my popular affiliates using these links: Paleovalley, Magic Spoon breakfast cereal, LMNT, Seeking Health, Ancestral Supplements. Find more affiliates here. For $2.99, you can purchase The Vitamins and Minerals 101 Cliff Notes, a bullet point summary of all the most important things I've learned in over 15 years of studying nutrition science. For $10, you can purchase The Food and Supplement Guide for the Coronavirus, my protocol for prevention and for what to do if you get sick (free if you become a paid subscriber to my Substack). For $15, you can pre-order a single format of my Vitamins and Minerals 101 book, my complete guide to nutrition, to be finished as soon as my work on COVID vaccines is done. For $25, you can pre-order a digital bundle of my Vitamins and Minerals 101 book. For $29.99, you can purchase a copy of my ebook, Testing Nutritional Status: The Ultimate Cheat Sheet, my complete system for managing your nutritional status using dietary analysis, a survey of just under 200 signs and symptoms, and a comprehensive guide to proper interpretation of labwork. For $35, you can pre-order a complete bundle of my Vitamins and Minerals 101 book. For a recurring $15/month or $120/year, you can join the CMJ Masterpass, with monthly access to live Zoom Q&A sessions with me, and huge discounts on my consulting, my informational products, and the health and wellness products from other companies that I value most. Paid Substack subscribers get 50% off the membership fee. For $250-$1499.99, you can work one-on-one with me. In any amount at all, you can make a donation to support my work on COVID vaccines during this time when our freedom of speech, bodily autonomy, and right to earn a living are all under attack.

TWiV reviews recent cases of monkeypox, presence of SARS-CoV-2 RNA but not infectious virus in feces, and the association of autoantibodies to interferons with severe COVID-19. Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, Kathy Spindler, and Brianne Barker Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Monkeypox in MA (ProMed Mail) Possible monkeypox in NYC (NY Times) Occupational monkeypox, Wisconsin (Emerg Inf Dis) SARS-CoV-2 in feces (Nature) IFN autoantibodies and severe COVID-19 (PNAS) Letters read on TWiV 902 Timestamps by Jolene. Thanks! Weekly Picks Dickson – How to grow food on the moon Brianne – APod May 16: Milky Way over French Alp Hoodoos Kathy – Covid Nationwide data visualization Rich – NIH All of Us Research Program Vincent – Physicians Spreading Misinformation on Social Media — Do Right and Wrong Answers Still Exist in Medicine? Listener Pick Lisa – E.H. Danner Museum of Telephony Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

Since the beginning of the pandemic there has been a debate amongst researchers about whether the body's immune cells can themselves be infected by SARS-CoV-2. Now two new studies show that they can - and what's more, the work has revealed a new mechanism for the massive inflammatory response seen in severe COVID. In this episode of Coronapod, we dig into the papers, asking why it has taken so long to get an answer to this question? How immune cell infection could lead to severe disease? And whether this new mechanism could provide a new avenue for the development of therapeutics?News: What triggers severe COVID? Infected immune cells hold cluesSubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday. See acast.com/privacy for privacy and opt-out information.

On this month's NCS Podcast Series episode, Andrew Bauerschmidt interviewed Lindsey Gurin in her recent article, “Early Neurorehabilitation and Recovery from Disorders of Consciousness After Severe COVID-19”. NCS offers free CE credits for the NCS Podcast Series episodes. Listen to any of the posted episodes, complete a five question survey, and claim your credits here! Credits are available for physicians, pharmacists, nurses, and non-physicians. The NCS Podcast is the official podcast of the Neurocritical Care Society. Our senior producer is Bonnie Rossow. Our host is Fawaz Almufti, and our production staff includes Tareq Saad Almaghrabi, Andrew Bauerschmidt, Leonid Groysman, Atul Kalanuria, Lauren Koffman, Kassi Kronfeld, Holly Ledyard, Lindsay Marchetti, Alexandra Reynolds, Lucia Rivera Lara, Jon Rosenberg, Jason Siegel, Zachary Threlkeld, Teddy Youn, and Chris Zammit. Our administrative staff includes Bonnie Rossow. Music by Mohan Kottapally.

Coronary CTA, semaglutide, coronary artery calcium, exercise, and an ACC and EHRA preview are the topics discussed by John Mandrola, MD, in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I – Coronary CTA Feedback - Coronary Computed Tomography Angiography vs Functional Stress Testing for Patients With Suspected Coronary Artery Disease https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2655243 II – Semaglutide - FDA Okays Semaglutide Higher Dose, 2 mg/Week, for Type 2 Diabetes https://www.medscape.com/viewarticle/971156 - Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial https://doi.org/10.1016/S2213-8587(21)00174-1 - Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://www.nejm.org/doi/full/10.1056/NEJMoa1607141 - Once-Weekly Semaglutide in Adults with Overweight or Obesity https://www.nejm.org/doi/full/10.1056/NEJMoa2032183 III – CAC and SCD - Calcium Scores Predict Sudden-Death Risk in Preclinical CAD in Large Cohort Study https://www.medscape.com/viewarticle/971056 - Coronary Artery Calcium for Risk Stratification of Sudden Cardiac Death: The Coronary Artery Calcium Consortium https://www.jacc.org/doi/10.1016/j.jcmg.2022.02.011 IV – Exercise and COVID-19 - More Exercise Linked to Lower Chance of Severe COVID-19: Study https://www.medscape.com/viewarticle/949468 - Small steps, strong shield: directly measured, moderate physical activity in 65 361 adults is associated with significant protective effects from severe COVID-19 outcomes http://dx.doi.org/10.1136/bjsports-2021-105159 V – ACC Preview - Hybrid ACC.22 Resurrects the Live Scientific Session https://www.medscape.com/viewarticle/971083 - Mandrola Previews the 2022 American College of Cardiology Scientific Sessions https://www.medscape.com/viewarticle/971084 You may also like: Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

A Colorado group moves from filling gaps in Ukraine's health care system to addressing upheaval from war. Then, a new study to help doctors predict which children with COVID end up severely ill and even die. And, how to limit angst in uncertain times. Also, Broncos fans hope for a new chapter. Plus, testing outdoor gear to address individual skill levels.

A Colorado group moves from filling gaps in Ukraine's health care system to addressing upheaval from war. Then, a new study to help doctors predict which children with COVID end up severely ill and even die. And, how to limit angst in uncertain times. Also, Broncos fans hope for a new chapter. Plus, testing outdoor gear to address individual skill levels.

FDA advisers voted to recommend emergency use authorization of a booster dose of Pfizer's vaccine six months after full vaccination in people 65 and older and those at high risk of severe Covid-19. CNN’s Chief Medical Correspondent Dr. Sanjay Gupta tells Anderson Cooper why the advisers didn’t recommend the booster for everyone 16 and older. Plus, CNN National Correspondent Randi Kaye gives AC360 an update on the search for Gabby Petito, the missing 22-year-old whose family last heard from her in late August. She was on a cross country road trip with her fiancé, who returned home to Florida without Petito and isn’t cooperating with the police. Airdate: September 17, 2021 Guests: Dr. Sanjay Gupta Randi KayeTo learn more about how CNN protects listener privacy, visit cnn.com/privacy